Jon Henry Therriault

Jon Henry Therriault is a Scientist at Mozart Therapeutics, Inc. since July 2021. Previously, as a Senior Associate Scientist at Bristol-Myers Squibb from January 2017 to June 2021, Jon developed downstream manufacturing processes for monoclonal antibodies and microbial drug conjugates, led multiple collaborative projects, and facilitated the transfer of innovative therapeutic modalities to GMP manufacturers. Jon’s earlier roles included Research Assistant I at Fornia Biosolutions and BioProcess Development Intern at ZymoGenetics, where skills in biochemical assay development and chromatography techniques were honed. Jon holds a Master of Science in Biomathematics, Bioinformatics, and Computational Biology from Northeastern University and a Bachelor's Degree in Biomolecular Engineering from Santa Clara University.